samedan logo
 
 
 
spacer
home > pmps > spring 2009 > confidence in compliance
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Confidence in Compliance

Patient adherence to medicinal therapy is the prerequisite of any successful treatment. Furthermore, it is the prerequisite for an economical and efficient way of curing illnesses, or improving the general level of human health. Despite this, compliance is not the rule, but the exception. Non-compliance is an issue for individuals whose condition may worsen, or who may even die if they fail to take medication correctly. It is, however, just as much a concern for the public, as non-compliance leads to losses in productivity and increased expenses for modern medication, for better and more efficient drugs. The subsequent cost of non-compliance is not only that of the wasted medicines, but also the cost of emergency and acute intervention when medication is not taken.

The US National Council on Patient Information and Education (NCPIE) states: “Perhaps it is no surprise that one of the most common examples of patients not following their prescription regimen involves antibiotic therapy, usually when they stop taking their medicine prematurely. This can cause a recurrence of the condition that the antibiotics were originally prescribed to treat” (1). What is even more problematic in this instance is that non-compliance can cause the bacteria to become resistant to the initially applied antibiotics.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Starting his career as an international Sales Manager, Tassilo Korab has been in the packaging industry for more than 20 years. A recognised expert in flexible packaging, he holds an MSc in Healthcare Economics, and has written several publications on patient compliance, standards and regulations for child resistant packaging and the war against counterfeits. Tassilo is currently Managing Director of TKM Handels GmbH, Vienna, a consulting company in the sector of flexible packaging for the pharmaceutical and healthcare industries. He was one of the co-founders of HCPC-Europe, the Healthcare Compliance Packaging Council, a not-for-profit organisation uniting the pharmaceutical industry, packaging materials suppliers, packaging machine manufacturers and patient organisations in their common endeavour to improve drug packaging design in the interest of the patients. He has been Executive Director since September 2005.
spacer
Tassilo Korab
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ROUSSELOT INTRODUCES X-PURE® GelMA FOR TRANSLATIONAL MEDICINE

Irving, United States [03 June 2020] — Rousselot, a Darling Ingredients brand and the global leader of collagen-based solutions, takes on the digital challenge and introduces X-Pure® GelMA at Bio Digital 2020. The first GMP-ready range of gelatin methacryloyl (GelMA) biomaterials suitable for preclinical and clinical applications, X-Pure® GelMA is part of the X-Pure portfolio of ultra-pure gelatins and collagens, suitable for use as biomaterials in 3D bioprinting, tissue engineering, and regenerative medicine.
More info >>

White Papers

The Power of Execution in Clinical Research

Medpace

Medpace, long known for its excellence in conducting Phase I-IV studies on a global platform, is particularly noted for its therapeutic excellence. When that expertise is combined with operational precision, the results are nothing short of stellar. The Medpace full-service outsourcing approach – combined with therapeutic expertise, regulatory know how, and global presence – delivers clinical studies with an industry recognized track record.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement